Quantum-Si (QSI) to Release Earnings on Wednesday

Quantum-Si (NASDAQ:QSI) is projected to issue its quarterly earnings data after the market closes on Wednesday, February 26th. Analysts expect the company to announce earnings of ($0.19) per share and revenue of $1.29 million for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link.

Quantum-Si Stock Performance

QSI opened at $1.92 on Wednesday. The company has a fifty day moving average of $2.22 and a two-hundred day moving average of $1.40. The stock has a market capitalization of $274.00 million, a price-to-earnings ratio of -3.00 and a beta of 2.69. Quantum-Si has a fifty-two week low of $0.61 and a fifty-two week high of $5.77.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on QSI shares. HC Wainwright reaffirmed a “buy” rating and issued a $5.50 price target on shares of Quantum-Si in a report on Tuesday, January 14th. Canaccord Genuity Group cut their price objective on Quantum-Si from $1.50 to $1.00 and set a “hold” rating for the company in a research note on Wednesday, November 13th. Finally, Alliance Global Partners started coverage on shares of Quantum-Si in a research report on Friday, February 7th. They issued a “buy” rating and a $3.75 target price for the company.

Insiders Place Their Bets

In other Quantum-Si news, Director Jonathan M. Rothberg sold 3,506,267 shares of Quantum-Si stock in a transaction on Friday, December 27th. The stock was sold at an average price of $3.34, for a total value of $11,710,931.78. Following the sale, the director now owns 1,250,000 shares in the company, valued at $4,175,000. The trade was a 73.72 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 30.04% of the company’s stock.

About Quantum-Si

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.